Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

Verfasser / Beitragende:
[Nina Cavalli-Björkman, Eva Ösby, Jeanette Lundin, Mats Kalin, Anders Österborg, Astrid Gruber]
Ort, Verlag, Jahr:
2002
Enthalten in:
Medical Oncology, 19/4(2002-12-01), 277-280
Format:
Artikel (online)
ID: 471159956